Skip to main content
. Author manuscript; available in PMC: 2022 Jun 15.
Published in final edited form as: Cardiol Clin. 2019 Aug 31;37(4):429–439. doi: 10.1016/j.ccl.2019.07.007

Fig. 4.

Fig. 4.

(A) Serial increases in a population of patients with breast cancer during and after treatment (B–E), and representative T2 images from a woman in whom T2 increased significantly (denoted by arrow in D) and who developed subepicardial scarring on late gadolinium enhancement (LGE) images 1 year after treatment (denoted by arrow in F). (From Lustberg MB, Reinbolt R, Addison D, et al. Early detection of anthracycline-induced cardiotoxicity in breast cancer survivors with T2 cardiac magnetic resonance. Circ Cardiovasc Imaging 2019;12(5):e008777; with permission.)